NF-κB: a key role in inflammatory diseases
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
NF-κB in defense and diseaseActivation of the NF-κB/Rel transcription family, by nuclear translocation of cytoplasmic complexes, plays a central role in inflammation through its ability to induce transcription of proinflammatory genes (1).This pathway is activated upon appropriate cellular stimulation, most often by signals related to pathogens or stress.Here we will discuss the specificity of various NF-κB proteins, their role in inflammatory disease, the regulation of NF-κB activity by IκB proteins and IκB kinase (IKK), and the development of therapeutic strategies aimed at inhibition of NF-κB. Functions of individual NF-κB proteins in immune cellsThe NF-κB/Rel family includes NF-κB1 (p50/p105), NF-κB2 (p52/p100), p65 (RelA), RelB, and c-Rel (2).Most members of this family (RelB being one exception) can homodimerize, as well as form heterodimers with each other.The most prevalent activated form of NF-κB is a heterodimer consisting of a p50 or p52 subunit and p65, which contains transactivation domains necessary for gene induction.Studies in knockout mice have shown distinct functions for different members of the NF-κB/Rel family.Various NF-κB proteins play a pivotal role in defense of the host against certain pathogens.Furthermore, lack of RelA leads to embryonic lethality and liver degeneration in knockout mice, whereas mice lacking p50 or RelB are immunodeficient but otherwise develop normally to adulthood.B cells from p50 knockout mice show abnormal mitogen responses and antibody production.RelB plays a role in the development and differentiation of dendritic cells, and a mutation disrupting relB impairs antigen presentation.Other NF-κB proteins, including C-Rel and p52, are also essential for normal immune function.Of interest, unlike either of the corresponding single knockout mice, p50/p52 double knockout mice exhibit impaired development of osteoclasts and B cells (3).The expression of NF-κB proteins can provide siteand event-specificity in response to a particular stimulus.For instance, IL-1-induced collagenase expression in synoviocytes is primarily activated by p50 homodimers that bind to a critical NF-κB-like binding site (4).Both p50 and p65 play a role in constitutive IL-6 pro-duction in rheumatoid arthritis (RA) synovial fibroblasts (5), whereas p65 activation by thrombin regulates ICAM-1 expression in endothelial cells (6).p50 and p65 heterodimers are intimately involved in activation of inflammatory genes by IL-1 or TNF-α in human monocytes, and these effects are blocked by the anti-inflammatory cytokine IL-10 (7).Additional specificity is provided by the expression patterns of other regulatory molecules, including surface receptors to proinflammatory cytokines as well as the hierarchy of IKK and IκB isotypes in each cell lineage (see below).These differences, along with multiple variations in NF-κB-like binding sites that interact with certain NF-κB hetero-and homodimers, permit cells to respond to the external environment at the appropriate time with the correct genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“We detected increased NF-κB activity in association with improved anti-microbial immune responses in hmox.sh macrophages, which is consistent with NF-kB as a central regulator of inflammatory responses (Tak and Firestein, 2001).”
From Heme oxygenase 1 controls early innate immune response of macrophages to Salmonella Typhimurium infection: Heme oxygenase 1 expression affects Salmonella infection (2016) · cites this paper as Tak and Firestein, 2001
In the citing paper
“Increased leukocyte adhesion has been appreciated as a marker for endothelial cell activation, especially in the pathological context of atherosclerosis.23, 24”
From Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB (2016) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711 · cited 2×
“In other lineages like hepatocytes and synovial cells, NF-κB plays an antiapoptotic role (24, 25).”
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Chen, Z., Hagler, J., Palombella, V. J., Melandri, F., Scherer, D., Ballard, D., & Maniatis, T. (1995) · Genes & Development · doi:10.1101/gad.9.13.1586 · Cited by 1,290 · cited 1×
“Phosphorylated IκBα is then ubiquitinated, which targets it for degradation by the 26S proteasome (13), thereby releasing NF-κB dimers from the cytoplasmic NF-κB–IκB complex and allowing them to translocate to the nucleus.”
Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., & Israël, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81466-x · Cited by 1,076
Requirement for NF-κB in osteoclast and B-cell development
Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F., & Siebenlist, U. (1997) · Genes & Development · doi:10.1101/gad.11.24.3482 · Cited by 996
Li, Z.-W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R., & Karin, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1839 · Cited by 926
NF-κB in neuronal plasticity and neurodegenerative disorders
Mattson, M. P., & Camandola, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11916 · Cited by 877
Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation
Delhase, M., Hayakawa, M., Chen, Y., & Karin, M. (1999) · Science · doi:10.1126/science.284.5412.309 · Cited by 852
Research works printed but not linked: 3
- Miyazawa, 1998, Am J Pathol, 152, 793
- Mengshol, 2000, Arthritis Rheum, 43, 801, 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4 · doi:10.1002/1529-0131(200004)43:4<801::aid-anr10>3.0.co;2-4
- Yokoo, 1996, Am J Physiol, 270, F123
Cited by
Items 201–300 of 1,017
New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells
Kimura, H., Caturegli, P., Takahashi, M., & Suzuki, K. (2015) · Journal of Immunology Research · doi:10.1155/2015/541984 · Cited by 162
Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
Coates, L. C., FitzGerald, O., Helliwell, P. S., & Paul, C. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.05.012 · Cited by 161
Ha, S. K., Moon, E., & Kim, S. Y. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.08.064 · Cited by 168
Gallic acid improved inflammation via NF-κB pathway in TNBS-induced ulcerative colitis
Zhu, L., Gu, P., & Shen, H. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2018.11.049 · Cited by 160
Chen, H., Chen, J., Li, M., Chang, M., Xu, K., Shang, Z., Zhao, Y., Palmer, I., Zhang, Y., McGill, J., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.10.019 · Cited by 165
“NPR1 protein in plants, which is required for the expressing of PR genes encoding antimicrobial proteins, is functionally equivalent to mammalian nuclear factor (NF)-kB protein, which promotes the expression of antimicrobial cytokines (Tak and Firestein, 2001).”
BackgroundEpigenetic modifications of inflammation in intervertebral disc degeneration
Kang, L., Zhang, H., Jia, C.-Y., Zhang, R., & Shen, C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101902 · Cited by 175
“It was also found that COX2 can increase the expression of IL-6, TNF-α, and IL-8, whereas DNMT3b can reverse this trend.”
BackgroundInfluentialHaller, D., Russo, M. P., Sartor, R. B., & Jobin, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205737200 · Cited by 165
Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease
Choi, B.-H., Kang, K.-S., & Kwak, M.-K. (2014) · Molecules · doi:10.3390/molecules190812727 · Cited by 159
Erratum: NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri968 · Cited by 165
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease
Jha, N. K., Jha, S. K., Kar, R., Nand, P., Swati, K., & Goswami, V. K. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14687 · Cited by 157
Rodrigo, R., & Bosco, C. (2006) · Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · doi:10.1016/j.cbpc.2005.11.002 · Cited by 162
“The nuclear factorkappaB (NF-κB) is one of the most important regulators of proinflammatory gene expression (Tak and Firestein, 2001), and it has been demonstrated that ROS can stimulate its activation in mesangial cells (Massy et al., 1999).”
BackgroundMechanisms of target organ damage caused by hypertension: Therapeutic potential
Cohuet, G., & Struijker-Boudier, H. A. J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.002 · Cited by 185
Endothelial cells: From innocent bystanders to active participants in immune responses
Al-Soudi, A., Kaaij, M. H., & Tas, S. W. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.008 · Cited by 152
Hidalgo, M. A., Romero, A., Figueroa, J., Cortés, P., Concha, I. I., Hancke, J. L., & Burgos, R. A. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706105 · Cited by 161
“In summary, the importance of NF-kB as a therapeutic target makes this transcription factor relevant to the development of new therapeutic strategies (Tak & Firestein, 2001; Ali & Mann, 2004; Karin et al., 2004).”
BackgroundWu, H.-H., Hwang-Verslues, W. W., Lee, W.-H., Huang, C.-K., Wei, P.-C., Chen, C.-L., Shew, J.-Y., Lee, E. Y.-H. P., Jeng, Y.-M., Tien, Y.-W., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141702 · Cited by 157
“Besides chemokines, numerous target genes of NF-B, which promote cell cycle activity, angiogenesis, anti-apoptosis, metastasis, and tumor progression, have been identified (Baldwin, 2001; Tak and Firestein, 2001; Yamamoto and Gaynor, 2001; Karin, 2006).”
BackgroundGoszcz, K., Duthie, G. G., Stewart, D., Leslie, S. J., & Megson, I. L. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13708 · Cited by 176
“Activation of the transcription factor NF-κB plays a crucial role in inflammation, mainly due to its induction of pro-inflammatory genes, thereby regulating the immune response (Tak and Firestein, 2001).”
BackgroundChen, B., Li, H., Ou, G., Ren, L., Yang, X., & Zeng, M. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1974-z · Cited by 165
NF-κB: A Stress-Regulated Switch for Cell Survival
Piva, R., Belardo, G., & Santoro, M. G. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.478 · Cited by 153
Hypothalamic inflammation and obesity: a mechanistic review
Seong, J., Kang, J. Y., Sun, J. S., & Kim, K. W. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01138-9 · Cited by 158
Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats
Panchal, S. K., Ward, L., & Brown, L. (2013) · European Journal of Nutrition · doi:10.1007/s00394-012-0358-9 · Cited by 158
Paiva, L. A. F., Gurgel, L. A., Silva, R., Tomé, A. R., Gramosa, N. V., Silveira, E. R., Santos, F. A., & Rao, V. S. N. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(03)00028-4 · Cited by 160
Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?
Gruben, N., Shiri‐Sverdlov, R., Koonen, D. P. Y., & Hofker, M. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.08.004 · Cited by 167
Yu, J., & Auwerx, J. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.12.006 · Cited by 154
Mu, N., Gu, J., Huang, T., Zhang, C., Shu, Z., Li, M., Hao, Q., Li, W., Zhang, W., Zhao, J.-K., et al. (2016) · Scientific Reports · doi:10.1038/srep20059 · Cited by 173
Chen, Y., Yang, B., Stanton, C., Ross, R. P., Zhao, J., Zhang, H., & Chen, W. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c06329 · Cited by 150
Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine
Rodrigo, R., & Rivera, G. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00908-5 · Cited by 170
Zhou, P., Lu, S., Luo, Y., Wang, S., Yang, K., Zhai, Y., Sun, G., & Sun, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00464 · Cited by 161
“NF-κB activation is indispensable for the regulation of critical factors responsible for the inflammatory reactions that play crucial roles in AS (Tak and Firestein, 2001).”
BackgroundPeng, Z., Zhang, C., Yan, L., Zhang, Y., Yang, Z., Wang, J., & Song, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051769 · Cited by 162
El‐Saadony, M. T., Saad, A. M., Mohammed, D. M., Alkafaas, S. S., Ghosh, S. B., Negm, S. H., Salem, H. M., Fahmy, M. A., Mosa, W. F. A., Ibrahim, E. H., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1603018 · Cited by 183
Liao, B., Hsieh, C., Liu, Y., Tzeng, T.-T., Sun, Y.-W., & Wung, B. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.01.021 · Cited by 165
Kim, M.-C., Kim, S., Kim, D., Jeon, Y., Park, S. J., Lee, H. S., Um, J., & Hong, S. (2011) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2010.547500 · Cited by 154
Guma, M., Stepniak, D., Shaked, H., Spehlmann, M. E., Shenouda, S., Cheroutre, H., Vicente-Suarez, I., Eckmann, L., Kagnoff, M. F., & Karin, M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110242 · Cited by 151
“…and nuclear localization have been consistently detected in biopsies from such patients, and are accompanied by enhanced recruitment of inflammatory cells and production of proinflammatory mediators such as IL-1, IL-6, and TNF (Barnes and Karin, 1997; Tak and Firestein, 2001; Pasparakis, 2009).”
Ethyl Pyruvate Inhibits Nuclear Factor-κB-Dependent Signaling by Directly Targeting p65
Han, Y., Englert, J. A., Yang, R., Delude, R. L., & Fink, M. P. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079707 · Cited by 155
“…is thought to play a pivotal role in immune and inflammatory responses through the regulation of genes encoding pro-inflammatory cytokines, adhesion molecules, chemokines, growth factors, and inducible enzymes, such as cyclooxygenase-2 and iNOS (Karin and Ben-Neriah, 2000; Tak and Firestein, 2001).”
BackgroundNuclear factor (NF)-κB proteins: therapeutic targets
Verma, I. M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.028266 · Cited by 171
Fornari Laurindo, L., Aparecido Dias, J., Cressoni Araújo, A., Torres Pomini, K., Machado Galhardi, C., Rucco Penteado Detregiachi, C., Santos de Argollo Haber, L., Donizeti Roque, D., Dib Bechara, M., Vialogo Marques de Castro, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305933 · Cited by 144
Hypercapnic Acidosis Attenuates Endotoxin-Induced Nuclear Factor-κB Activation
Takeshita, K., Suzuki, Y., Nishio, K., Takeuchi, O., Toda, K., Kudo, H., Miyao, N., Ishii, M., Sato, N., Naoki, K., et al. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0126oc · Cited by 153
“NF-B is found in the cytoplasm in an inactive form joined with regulatory proteins called IB, in which the important isoforms are IB- and IB- ( 17 ).”
BackgroundLidbury, B. A., Rulli, N. E., Suhrbier, A., Smith, P. N., McColl, S. R., Cunningham, A. L., Tarkowski, A., van Rooijen, N., Fraser, R. J., & Mahalingam, S. (2008) · The Journal of Infectious Diseases · doi:10.1086/587841 · Cited by 152
Jansen, G., Scheper, R. J., & Dijkmans, B. A. C. (2003) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740310004333 · Cited by 243
Metformin Down-regulates TNF-α Secretion via Suppression of Scavenger Receptors in Macrophages
Hyun, B., Shin, S., Lee, A., Lee, S., Song, Y., Ha, N.-J., Cho, K.-H., & Kim, K. (2013) · Immune Network · doi:10.4110/in.2013.13.4.123 · Cited by 148
Ocaña-Fuentes, A., Arranz, E., Señoráns, F. J., & Reglero, G. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.03.026 · Cited by 168
van Holten, J., Reedquist, K. A., Sattonnet‐Roche, P., Smeets, T. J. M., Plater-Zyberk, C., Vervoordeldonk, M. J., & Tak, P. P. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1165 · Cited by 170
Self-citationCárdeno, A., Aparicio-Soto, M., Montserrat-de la Paz, S., Bermudez, B., Muriana, F. J. G., & Alarcón-de-la-Lastra, C. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.03.009 · Cited by 140
Crascì, L., Lauro, M. R., Puglisi, G., & Panico, A. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1229657 · Cited by 155
Irrera, N., Vaccaro, M., Bitto, A., Pallio, G., Pizzino, G., Lentini, M., Arcoraci, V., Minutoli, L., Scuruchi, M., Cutroneo, G., et al. (2017) · Clinical Science · doi:10.1042/cs20160645 · Cited by 146
Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients
Chemel, M., Goff, B. L., Brion, R., Cozic, C., Berreur, M., Amiaud, J., Bougras-Cartron, G., Touchais, S., Blanchard, F., Heymann, M., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200096 · Cited by 147
García‐Piñeres, A., Lindenmeyer, M. T., & Merfort, I. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.01.024 · Cited by 148
Suppressive Effects of the Kahweol and Cafestol on Cyclooxygenase-2 Expression in Macrophages
Kim, J. Y., Jung, K. S., & Jeong, H. G. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.05.070 · Cited by 146
STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
Lee, C., & Cheung, S. (2019) · Cancers · doi:10.3390/cancers11111646 · Cited by 156
“Particularly, activation of STAT3 has been found to be associated with nuclear factor-kappa B (NF-kB), a family of inflammatory transcription factors consisting of NF-κB1 (p50), NF-κB2 (p52), Rel-A (p65), Rel-B and c-Rel subunits [41].”
BackgroundYue, H., Brown, M., Knowles, J., Wang, H., Broomhead, D. S., & Kell, D. B. (2006) · Molecular BioSystems · doi:10.1039/b609442b · Cited by 148
Bao, S., Liu, M.-J., Lee, B., Besecker, B., Lai, J.-P., Guttridge, D. C., & Knoell, D. L. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00368.2009 · Cited by 147
Avasarala, S., Zhang, F., Liu, G., Wang, R., London, S. D., & London, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057285 · Cited by 148
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
Jiang, Y.-Z., Rubin, L., Peng, T., Liu, L., Xing, X., Lazarovici, P., & Zheng, W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59272 · Cited by 163
Rheumatoid Arthritis Synoviocyte Survival Is Dependent on Stat3
Krause, A., Scaletta, N., Ji, J.-D., & Ivashkiv, L. B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6610 · Cited by 143
Wu, Y., Du, S., Johnson, J. L., Tung, H.-Y., Landers, C. T., Liu, Y., Seman, B. G., Wheeler, R. T., Costa-Mattioli, M., Kheradmand, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07991-4 · Cited by 143
Lee, S.-B., Lee, W. S., Shin, J., Jang, D. S., & Lee, K. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.021 · Cited by 146
Transfer of regulatory knowledge from human to mouse for functional genomics analysis
Holland, C. H., Szalai, B., & Sáez-Rodríguez, J. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.194431 · Cited by 163
Tuning NF-κB activity: A touch of COMMD proteins
Bartuzi, P., Hofker, M. H., & van de Sluis, B. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.014 · Cited by 121
Kurgan, S., & Kantarci, A. (2018) · Periodontology 2000 · doi:10.1111/prd.12146 · Cited by 141
TFEB inhibits endothelial cell inflammation and reduces atherosclerosis
Lu, H., Fan, Y., Qiao, C., Liang, W., Hu, W., Zhu, T., Zhang, J., & Chen, Y. E. (2017) · Science Signaling · doi:10.1126/scisignal.aah4214 · Cited by 143
Prescott, J. A., & Cook, S. J. (2018) · Cells · doi:10.3390/cells7090115 · Cited by 139
Satoh, A., Gukovskaya, A. S., Nieto, J. M., Cheng, J. H., Gukovsky, I., Reeve, J. R., Shimosegawa, T., & Pandol, S. J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00087.2004 · Cited by 144
Anti-Inflammatory Effects of Lutein in Retinal Ischemic/Hypoxic Injury: In Vivo and In Vitro Studies
Li, S.-Y., Fung, F. K. C., Fu, Z. J., Wong, D., Chan, H. H. L., & Lo, A. C. Y. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10007 · Cited by 137
Li, T., Li, F., Liu, X., Liu, J., & Li, D. (2019) · Phytotherapy Research · doi:10.1002/ptr.6268 · Cited by 156
Ting, H. J., Stice, J. P., Schaff, U. Y., Hui, D. Y., Rutledge, J. C., Knowlton, A. A., Passerini, A. G., & Simon, S. I. (2007) · Circulation Research · doi:10.1161/01.res.0000258023.76515.a3 · Cited by 138
Kang, C.-H., Choi, Y. H., Moon, S.-K., Kim, W.-J., & Kim, G.-Y. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.09.009 · Cited by 138
Sancho, R., Lucena, C., Macho, A., Calzado, M. A., Blanco-Molina, M., Minassi, A., Appendino, G., & Muñoz, E. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200206)32:6<1753::aid-immu1753>3.0.co;2-2 · Cited by 138
Control of autoimmune inflammation by celastrol, a natural triterpenoid
Venkatesha, S. H., Dudics, S., Astry, B., & Moudgil, K. D. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw059 · Cited by 148
“This in turn blocks the activation of NF-κB and its nuclear translocation, and thereby, inhibits the expression of NF-κB-regulated target genes (Tak and Firestein 2001; Simmonds and Foxwell 2008).”
BackgroundDamaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes
Kaustio, M., Haapaniemi, E. M., Göös, H., Hautala, T., Park, G., Syrjänen, J., Einarsdóttir, E., Sahu, B., Kilpinen, S., Rounioja, S., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.10.054 · Cited by 148
Models in the Research Process of Psoriasis
Bocheńska, K., Smolińska, E., Moskot, M., Jakóbkiewicz-Banecka, J., & Gabig-Cimińska, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122514 · Cited by 132
Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections
Dijsselbloem, N., Berghe, W. V., Naeyer, A. D., & Haegeman, G. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.036 · Cited by 151
Clinical Implications of Inflammatory Cytokines in the Cochlea: A Technical Note
Adams, J. C. (2002) · Otology & Neurotology · doi:10.1097/00129492-200205000-00015 · Cited by 138
Melatonin Reduces Inflammatory Injury through Inhibiting NF‐κ B Activation in Rats with Colitis
Li, J.-H., Yu, J.-P., Yu, H.-G., Xu, X.-M., Yu, L.-L., Liu, J., & Luo, H.-S. (2005) · Mediators of Inflammation · doi:10.1155/mi.2005.185 · Cited by 139
“Translocation into the nucleus and binding to target DNA sequences are important events for NF-κB to control transcription process, which relies on phosphorylation of IκB, mediated by IκB kinases (IKK-α, β), followed by its degradation by the proteasome [8, 11].”
BackgroundHadad, N., & Lévy, R. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.078 · Cited by 160
Sultani, M., Stringer, A. M., Bowen, J. M., & Gibson, R. J. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/490804 · Cited by 179
“NFκB is considered a key “driver” of chemotherapy-induced mucositis as its activation correlates with the production of TNF, IL-6 and IL-1β the hallmarks of mucositis inflammation [8, 36].”
BackgroundTumor necrosis factor–α contributes to below‐level neuropathic pain after spinal cord injury
Peng, X., Zhou, Z., Glorioso, J. C., Fink, D. J., & Mata, M. M. (2006) · Annals of Neurology · doi:10.1002/ana.20855 · Cited by 147
Kim, H., Kang, C., Jayasooriya, R. G. P. T., Dilshara, M. G., Lee, S., Choi, Y. H., Seo, Y. T., & Kim, G. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.03.022 · Cited by 139
Ying, X., Chen, X., Cheng, S., Shen, Y. L., Peng, L., & Xu, H. Z. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.06.025 · Cited by 155
Chadwick, C. C., Chippari, S., Matelan, E., Borges-Marcucci, L., Eckert, A. M., Keith, J. C., Albert, L. M., Leathurby, Y., Harris, H. A., Bhat, R. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405841102 · Cited by 137
Anti-inflammatory activity of c-phycocyanin in lipopolysaccharide-stimulated RAW 264.7 macrophages
Cherng, S.-C., Cheng, S.-N., Tarn, A., & Chou, T.-C. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.09.009 · Cited by 136
Quercetin topical application, from conventional dosage forms to nanodosage forms
Hatahet, T., Morille, M., Hommoss, A., Devoisselle, J., Müller, R. H., & Bégu, S. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.08.011 · Cited by 153
Domitrović, R., Škoda, M., Vasiljev, V., Cvijanović, O., Pugel, E. P., & Štefan, M. B. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.021 · Cited by 135
Majumder, K., Mine, Y., & Wu, J. (2016) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.7600 · Cited by 141
Chen, Y., Jialing, Q., Chen, B., Lin, Y., Chen, Y., Xie, G., Qiu, J., Tong, H., & Jiang, D. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.023 · Cited by 148
RetractedOrtega, R. H., Cerezo, A. B., de Pablos, R. M., Krisa, S., Richard, T., García-Parrilla, M. C., & Troncoso, A. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00373 · Cited by 144
“Then, these dimers are translocated to the nucleus regulating the expression of numerous target genes (TNF-α, iNOS, IL-1β, and IL-6 among others) (Tak and Firestein, 2001; Rahman and Fazal, 2011).”
BackgroundHepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action
Elufioye, T. O., & Habtemariam, S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108600 · Cited by 140
Yin, X., Yin, Y., Cao, F.-L., Chen, Y., Ye, P., Hou, W., Sun, S.-K., & Luo, Z.-J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038381 · Cited by 133
“. Moreover, there are several pathways to modulate these inflammatory factors, such as NF-κB and MAPKs pathways”
BackgroundNOD-like receptors: major players (and targets) in the interface between innate immunity and cancer
Velloso, F. J., Trombetta-Lima, M., Anschau, V., Sogayar, M. C., & Correa, R. G. (2019) · Bioscience Reports · doi:10.1042/bsr20181709 · Cited by 134
PACAP in Immunity and Inflammation
Delgado, M., Abad, C., Martínez, C., Juarranz, Y., Leceta, J., Ganea, D., & Gomariz, R. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03145.x · Cited by 133
Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?
Noort, A. R., Tak, P. P., & Tas, S. W. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0527-3 · Cited by 146
Self-citationCantaert, T., Baeten, D., Tak, P. P., & van Baarsen, L. G. M. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3150 · Cited by 146
“Upon binding to TNFR1 (which is constitutively expressed on most cell types) or TNFR2 (which is expressed on immune cells, endothelial cells and fi broblasts), TNFα activates the mitogen-activated protein kinase and NF-κB signaling pathways [ 3 ] – which in turn can lead to an amplifi cation of the proinfl ammatory re…”
BackgroundSelf-citationRusso, I., Berti, G., Plotegher, N., Bernardo, G., Filograna, R., Bubacco, L., & Greggio, E. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0449-7 · Cited by 128
Matsubara, M., Tamura, T., Ohmori, K., & Hasegawa, K. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.10.006 · Cited by 144
Expression of Smad7 in Mouse Eyes Accelerates Healing of Corneal Tissue after Exposure to Alkali
Saika, S., Ikeda, K., Yamanaka, O., Miyamoto, T. K., Ohnishi, Y., Sato, M., Muragaki, Y., Ooshima, A., Nakajima, Y., Kao, W. W. ‐., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62358-9 · Cited by 138
Park, T., Chen, H., Kevala, K., Lee, J.-W., & Kim, H.-Y. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0751-z · Cited by 131
Kim, H. G., Yoon, D. H., Lee, W. H., Han, S. K., Shrestha, B., Kim, C. H., Lim, M. H., Chang, W., Lim, S., Choi, S., et al. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.08.011 · Cited by 148
Pathogenesis and pharmacotherapy of Hidradenitis suppurativa
Nazary, M., van der Zee, H. H., Prens, E. P., Folkerts, G., & Boer, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.047 · Cited by 141
Zhang, S., Jiang, C., Liu, H., Guan, Z., Zeng, Q., Zhang, C., Lei, R., Xia, T., Gao, H. Y., Yang, L., et al. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.04.033 · Cited by 136
Curcumin prevents and reverses murine cardiac hypertrophy
Li, H.-L., Liu, C., de Couto, G., Ouzounian, M., Sun, M., Wang, A.-B., Huang, Y., He, C., Shi, Y., Chen, X., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32865 · Cited by 139
RetractedInflammatory signalling pathways involved in astroglial activation by unconjugated bilirubin
Fernandes, A., Falcão, A. S., Silva, R. F. M., Gordo, A. C., Gama, M. J., Brito, M. A., & Brites, D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03680.x · Cited by 130
“Interestingly, the induction of these signal effectors preceded the early up-regulation of TNF-a and interleukin (IL)-1b mRNAs, and later secretion of TNF-a, IL-1b and IL-6.”
BackgroundInfluentialMongolians core gut microbiota and its correlation with seasonal dietary changes
Zhang, J., Guo, Z., Lim, A. A. Q., Zheng, Y., Koh, E. Y., Ho, D., Qiao, J., Huo, D., Hou, Q., Huang, W., et al. (2014) · Scientific Reports · doi:10.1038/srep05001 · Cited by 123
Metadata
- Authors
- Tak, P. P., & Firestein, G. S.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Corresponding author
- Tak, Paul P.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-01-01
- Volume
- 107
- Issue
- 1
- Pages
- 7-11
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC198552
- OpenAlex
- W2064711537
- Cited by
- 3,918
- References
- 52
- Citations by year
- 2026: 89 · 2025: 173 · 2024: 163 · 2023: 172 · 2022: 174 · 2021: 214 · 2020: 257 · 2019: 277 · 2018: 279 · 2017: 286 · 2016: 209 · 2015: 231 · 2014: 196 · 2013: 189 · 2012: 125
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- UvA-DARE (University of Amsterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, Rel family transcription factors, inflammation, IκB proteins, IκB kinase, RelA/p65, P50, p52, RelB, c-Rel, immune cell development, host defense against infection, rheumatoid arthritis, synovial fibroblasts, osteoclasts, dendritic cells, IL-1 signaling
- MeSH terms
- Animals, Disease Models, Animal, DNA-Binding Proteins, Humans, Immunity, Inflammation, NF-kappa B, Protein Serine-Threonine Kinases, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.